MedTrace Logo

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?

NCT00534261 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 284

Last updated 2007-12-13

No results posted yet for this study

Summary

This study was to find out if patients with Relapsing Remitting Multiple Sclerosis treated with Interferon beta-1a had an improved quality of life after treatment with Interferon beta-1a

Conditions

  • Relapsing Remitting Multiple Sclerosis

Interventions

DRUG

Interferon beta-1a

IM injection

Sponsors & Collaborators

Principal Investigators

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-11-30
Completion
2004-02-29

Countries

  • Belgium
  • Luxembourg
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00534261 on ClinicalTrials.gov